<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/21/360eee–4" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/21/360eee–4/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/21/360eee–4/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_360eee_4"><akn:num>360eee–4</akn:num><akn:heading>Uniform national policy</akn:heading><akn:content><akn:p>§ 360eee–4. Uniform national policy(a) Product tracing and other requirementsBeginning on November 27, 2013, no State or political subdivision of a State may establish or continue in effect any requirements for tracing products through the distribution system (including any requirements with respect to statements of distribution history, transaction history, transaction information, or transaction statement of a product as such product changes ownership in the supply chain, or verification, investigation, disposition, notification, or recordkeeping relating to such systems, including paper or electronic pedigree systems or for tracking and tracing drugs throughout the distribution system) which are inconsistent with, more stringent than, or in addition to, any requirements applicable under section 353(e) of this title or this part (or regulations issued thereunder), or which are inconsistent with—(1) any waiver, exception, or exemption pursuant to section 360eee or 360eee–1 of this title; or

(2) any restrictions specified in section 360eee–1 of this title.


(b) Wholesale distributor and third-party logistics provider standards(1) In generalBeginning on November 27, 2013, no State or political subdivision of a State may establish or continue any standards, requirements, or regulations with respect to wholesale prescription drug distributor or third-party logistics provider licensure that are inconsistent with, less stringent than, directly related to, or covered by the standards and requirements applicable under section 353(e) of this title, in the case of a wholesale distributor, or section 360eee–3 of this title, in the case of a third-party logistics provider.


(2) State regulation of third-party logistics providersNo State shall regulate third-party logistics providers as wholesale distributors.


(3) Administration feesNotwithstanding paragraph (1), a State may administer fee collections for effectuating the wholesale drug distributor and third-party logistic</akn:p></akn:content><akn:subsection eId="subsec_360eee_4_a"><akn:num>(a)</akn:num><akn:heading>Product tracing and other requirements</akn:heading><akn:content><akn:p>(a) Product tracing and other requirements Beginning on November 27, 2013, no State or political subdivision of a State may establish or continue in effect any requirements for tracing products through the distribution system (including any requirements with respect to statements of distribution history, transaction history, transaction information, or transaction statement of a product as such product changes ownership in the supply chain, or verification, investigation, disposition, notification, or recordkeeping relating to such systems, including paper or electronic pedigree systems or for tracking and tracing drugs throughout the distribution system) which are inconsistent with, more stringent than, or in addition to, any requirements applicable under section 353(e) of this title or this part (or regulations issued thereunder), or which are inconsistent with—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_360eee_4_b"><akn:num>(b)</akn:num><akn:heading>Wholesale distributor and third-party logistics provider standards</akn:heading><akn:content><akn:p>(b) Wholesale distributor and third-party logistics provider standards</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_360eee_4_c"><akn:num>(c)</akn:num><akn:heading>Exception</akn:heading><akn:content><akn:p>(c) Exception Nothing in this section shall be construed to preempt State requirements related to the distribution of prescription drugs if such requirements are not related to product tracing as described in subsection (a) or wholesale distributor and third-party logistics provider licensure as described in subsection (b) applicable under section 353(e) of this title or this part (or regulations issued thereunder).</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>